CoChat

A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Effects of Oral Centella asiatica Extract on Skin Aging-Related Parameters in Middle-Aged Korean Women.

Open access
Hur, Nayon, Seo, Youngha, Bae, Jaewoo, Kim, Young Jun, Kim, Eun Ji, Choi, Yean Jung · 2026 · Nutrients

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index, and 1 are not checked yet; 59 of the 80 sources its claims cite were checked for support.

Abstract

Background: Centella asiatica has been widely recognized for its dermatological benefits; however, clinical evidence supporting the efficacy of oral supplementation for improving skin aging parameters remains limited. This randomized, double-blind, placebo-controlled study evaluated the effects of oral Centella asiatica extract on skin wrinkles and related skin parameters in middle-aged women. Methods: A total of 112 participants were randomized to receive either Centella asiatica extract (200 mg/day) or placebo for 12 weeks. Skin wrinkle parameters were quantitatively assessed using a three-dimensional skin imaging system (PRIMOS®). Skin hydration, transepidermal water loss (TEWL), elasticity, and skin color (brightness and redness) were additionally measured using validated non-invasive instruments. Efficacy analyses were performed in the per-protocol population. Results: After 12 weeks of supplementation, the Centella asiatica extract group demonstrated significant improvements in multiple wrinkle parameters compared with the baseline. Average wrinkle depth decreased by 11.1%, and the mean depth of the largest wrinkle decreased by 14.4%. Maximum wrinkle depth and total wrinkle volume were reduced by 13.3% and 13.7%, respectively, while surface roughness (Ra) decreased by 10.4%. In contrast, the placebo group showed minimal or inconsistent changes. Epidermal hydration at the cheek site significantly increased, while transepidermal water loss decreased, indicating improved skin barrier function. However, the magnitude of changes in epidermal hydration (2.7%), skin elasticity (R2; 0.7%), and skin brightness (L*; 0.7%) were relatively small. Skin elasticity and skin brightness showed statistically significant differences compared with the placebo group (p < 0.05), but these changes should be interpreted as modest improvements. No serious adverse events were reported, and all hematological and biochemical safety markers remained within normal reference ranges during the 12-week intervention period. Conclusions: Oral supplementation with Centella asiatica extract for 12 weeks was associated with improvements in wrinkle-related parameters and TEWL, while changes in skin hydration, elasticity, and brightness were modest and of limited magnitude. These findings suggest a potential role for short-term supplementation; however, further studies are required to confirm long-term efficacy and broader applicability.

Verified 2026-11-19 · 1 reference not checked yet

Overview

CoChat Summary

TL;DR

This 12-week randomized, double-blind, placebo-controlled trial found that oral Centella asiatica extract (200 mg/day) improved several objective skin-aging measures in middle-aged Korean women, especially wrinkle parameters and cheek-site hydration/barrier function. The authors describe the hydration, elasticity, and brightness effects as modest, and note that long-term efficacy and safety were not established.

Key findings

  • 112 participants were randomized 1:1 to Centella asiatica extract or placebo; 105 were included in the per-protocol analysis.
  • At week 12, the extract group showed greater improvement than placebo in the primary endpoint, average wrinkle depth: change from baseline was −5.87 ± 7.82 μm vs. −1.96 ± 6.09 μm (p = 0.018). The extract group also improved in mean depth of the biggest wrinkle (−10.36 ± 16.08 μm vs. −3.04 ± 12.58 μm; p = 0.011), total wrinkle volume (−0.30 ± 0.38 mm³ vs. −0.10 ± 0.33 mm³; p = 0.004), and surface roughness (p = 0.023).
  • Cheek skin hydration increased in the extract group from 44.83 ± 4.73 to 48.09 ± 5.08 A.U. by week 12, with significant between-group differences at week 6 (p = 0.008) and week 12 (p < 0.001). Cheek TEWL decreased from 11.48 ± 2.60 to 9.44 ± 1.79 g/hm², with between-group differences at week 6 (p = 0.020) and week 12 (p = 0.005).
  • Skin elasticity and brightness also improved modestly: elasticity R2 rose from 0.7309 ± 0.0501 to 0.7363 ± 0.0496 (p < 0.001 vs. baseline; p = 0.024 vs. placebo at week 12), and brightness L* rose from 63.99 ± 2.12 to 64.44 ± 2.05 (p < 0.001 vs. baseline; p < 0.001 vs. placebo at week 12). Redness decreased in both groups without significant between-group differences.
  • Safety outcomes were reassuring: 3 adverse events occurred total (1 extract, 2 placebo), all judged unrelated to the product, and laboratory values stayed within normal ranges.

Methods

  • 12-week, randomized, double-blind, placebo-controlled, parallel-group human intervention trial conducted in Korea (January 2025 to May 2025).
  • Participants: 116 screened, 112 randomized; middle-aged Korean women aged 30–60 with visible facial wrinkles and specified skin criteria; 105 completed the per-protocol analysis.
  • Intervention and analysis: Centella asiatica extract 200 mg/day vs placebo; primary endpoint was change in average wrinkle depth at week 12. Outcomes were measured with validated non-invasive instruments (PRIMOS, Corneometer, Moisturemeter, Tewameter, Cutometer, spectrophotometer) and analyzed mainly with paired t-tests/Wilcoxon tests for within-group changes and t-tests/Mann–Whitney tests for between-group comparisons.

Limitations

  • Stated by the paper: the sample consisted exclusively of middle-aged women, limiting generalizability to other ages, sexes, and skin types; only one dose was tested, so dose–response relationships were not assessed; direct mechanistic biomarkers were not measured; the intervention lasted only 12 weeks, so long-term efficacy/safety remain unknown; multiple endpoints were tested without multiplicity adjustment, increasing type I error risk.
  • Evident from the text: some outcomes were small in magnitude (for example, the authors repeatedly describe changes in elasticity and brightness as modest), so clinical significance may be limited even when statistical significance was reached.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu18101505

Cites

56 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study design and participant flow diagram. A total of 116 individuals were screened for eligibility, and 112 participants were randomized to receive either Centella asiatica extract (InnerCica™, n = 56) or placebo (n = 56). During the intervention period, six participants discontinued the study, and one participant was excluded from the per-protocol population due to abnormal blood test results. Finally, 53 participants in the extract group and 52 participants in the placebo group were included in the PP analysis.
Figure 1 Study design and participant flow diagram. A total of 116 individuals were screened for eligibility, and 112 participants were randomized to receive either Centella asiatica extract (InnerCica™, n = 56) or placebo (n = 56). During the intervention period, six participants discontinued the study, and one participant was excluded from the per-protocol population due to abnormal blood test results. Finally, 53 participants in the extract group and 52 participants in the placebo group were included in the PP analysis.CC BY · PubMed Central
Figure 2 Representative improvement of periorbital wrinkles following oral supplementation with Centella asiatica extract. Representative three-dimensional skin surface images of the periorbital region obtained at (A) baseline, (B) Week 6, and (C) Week 12 using a PRIMOS® three-dimensional skin imaging system. The pseudo-color scale represents wrinkle depth (µm), with cooler colors (blue–black) indicating deeper wrinkle regions and warmer colors (yellow–red) indicating shallower skin surface areas. Representative images from a participant in the Centella asiatica extract group illustrate a visible reduction in wrinkle depth and surface roughness over the 12-week supplementation period. Arrows indicate representative regions demonstrating reductions in wrinkle depth and surface irregularity following supplementation. Image size: 14 mm (H) × 22 mm (W). Surface topography is represented by a color-coded scale ranging from −200 μm (depressed regions, black/blue) to +100 μm (elevated regions, yellow).
Figure 2 Representative improvement of periorbital wrinkles following oral supplementation with Centella asiatica extract. Representative three-dimensional skin surface images of the periorbital region obtained at (A) baseline, (B) Week 6, and (C) Week 12 using a PRIMOS® three-dimensional skin imaging system. The pseudo-color scale represents wrinkle depth (µm), with cooler colors (blue–black) indicating deeper wrinkle regions and warmer colors (yellow–red) indicating shallower skin surface areas. Representative images from a participant in the Centella asiatica extract group illustrate a visible reduction in wrinkle depth and surface roughness over the 12-week supplementation period. Arrows indicate representative regions demonstrating reductions in wrinkle depth and surface irregularity following supplementation. Image size: 14 mm (H) × 22 mm (W). Surface topography is represented by a color-coded scale ranging from −200 μm (depressed regions, black/blue) to +100 μm (elevated regions, yellow).CC BY · PubMed Central
Figure 3 Changes in periorbital wrinkle parameters following oral supplementation with Centella asiatica extract (InnerCica™). Changes in key wrinkle parameters assessed using a PRIMOS® three-dimensional skin imaging system at baseline, Week 6, and Week 12. The evaluated parameters include (A) average wrinkle depth, (B) mean depth of the biggest wrinkle, (C) total wrinkle volume, and (D) surface roughness (Ra). Values are presented as mean ± SD (per-protocol analysis). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. placebo group.
Figure 3 Changes in periorbital wrinkle parameters following oral supplementation with Centella asiatica extract (InnerCica™). Changes in key wrinkle parameters assessed using a PRIMOS® three-dimensional skin imaging system at baseline, Week 6, and Week 12. The evaluated parameters include (A) average wrinkle depth, (B) mean depth of the biggest wrinkle, (C) total wrinkle volume, and (D) surface roughness (Ra). Values are presented as mean ± SD (per-protocol analysis). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. placebo group.CC BY · PubMed Central
Figure 4 Changes in skin hydration following oral supplementation with Centella asiatica extract (InnerCica™). Changes in epidermal hydration at the cheek site measured using a Corneometer®, and dermal hydration measured using a Moisturemeter® over 12 weeks. The evaluated parameters include (A) cheek epidermal hydration, (B) cheek dermal hydration, (C) cheek transepidermal water loss (TEWL), and (D) skin brightness (L* value). Values are presented as mean ± SD (per-protocol analysis). Compared with placebo, the Centella asiatica extract group showed significant increases in hydration, particularly at the cheek site. ** p < 0.01, *** p < 0.001 vs. placebo group.
Figure 4 Changes in skin hydration following oral supplementation with Centella asiatica extract (InnerCica™). Changes in epidermal hydration at the cheek site measured using a Corneometer®, and dermal hydration measured using a Moisturemeter® over 12 weeks. The evaluated parameters include (A) cheek epidermal hydration, (B) cheek dermal hydration, (C) cheek transepidermal water loss (TEWL), and (D) skin brightness (L* value). Values are presented as mean ± SD (per-protocol analysis). Compared with placebo, the Centella asiatica extract group showed significant increases in hydration, particularly at the cheek site. ** p < 0.01, *** p < 0.001 vs. placebo group.CC BY · PubMed Central

Verification

Claims the paper makes

23 Valid · 2 Not valid · 3 Not checked · 133 Own results and interpretations

63 more claims

Create a free account to see all 161 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 37
  • It may state two separate claims as one. 71

Create a free account to see these claims.

Citations

Cites

Cited by

See all 1

Metadata

Authors
Hur, N., Seo, Y., Bae, J., Kim, Y. J., Kim, E. J., & Choi, Y. J.
Affiliations
  • Korea University (KR)
  • 3H LABS Research Institute, 3H LABS Co., Ltd., Goyang 10391, Republic of Korea
  • Department of Food Regulatory Science, Korea University, Sejong 30019, Republic of Korea
  • Sahmyook University (KR)
Corresponding author
Choi, Yean Jung
Venue
Nutrients
Publisher
MDPI AG
Published
2026-05-08
Volume
18
Issue
10
Pages
1505
ISSN
2072-6643 (ISSN-L)
OpenAlex
W7160853966
Cited by
0
References
57
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Dermatology › Facial Rejuvenation and Surgery Techniques
Keywords
Centella asiatica, oral supplementation, skin aging, wrinkles, wrinkle depth, skin hydration, transepidermal water loss, skin elasticity, skin brightness, skin barrier function, middle-aged women
MeSH terms
East Asian People, Administration, Oral, Adult, Double-Blind Method, Elasticity, Female, Humans, Middle Aged, Plant Extracts, Skin, Skin Pigmentation, Triterpenes, Water Loss, Insensible, Skin Aging, Centella

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.